Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.14−0.10 (-4.46%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Biodexa Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Biodexa Pharmaceuticals's enterprise value was -$3.00M on Nov 11, 2026, against $3.63M a year earlier. Over the last 5 years it ranged from -$9.48M to $59.17B, with a median of $5.52M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.00M | – |
| 2025 | Dec 31, 2025 | -$930.08K | – |
| 2024 | Dec 31, 2024 | -$952.17K | – |
| 2023 | Dec 29, 2023 | -$4.64M | -100.0% |
| 2022 | Dec 30, 2022 | $10.61B | -82.1% |
| 2021 | Dec 31, 2021 | $59.17B | +22011.7% |
| 2020 | Dec 31, 2020 | $267.60M | +223.1% |
| 2019 | Dec 31, 2019 | $82.82M | -45.0% |
| 2018 | Dec 31, 2018 | $150.59M | -74.2% |
| 2017 | Dec 29, 2017 | $583.32M | -62.1% |
| 2016 | Dec 30, 2016 | $1.54B | – |
See a number that looks wrong?